CBP Antibody: PerCP
Référence MBS8000982-0,1mg
Conditionnement : 0.1mg
Marque : MyBiosource
CBP Antibody – Rabbit Polyclonal
For Research Use Only. Not for use in diagnostic procedures. Catalog #: MBS8000982MBS8000982 is an antibody targeting CBP. Also known as CBP Antibody: PerCP. Reactive in Human. Host: Rabbit. More details
DISCONTINUED
Click here to view our similar product(s) OR click here to contact our technical support team for suitable replacement.
Click here to view our similar product(s) OR click here to contact our technical support team for suitable replacement.
Product Overview
Product Name
CBP, Polyclonal Antibody
Full Product Name
CBP Antibody: PerCP
Product Gene Name
anti-CBP antibody
Product Synonym Names
Rabbit Anti-Human CBP Polyclonal; RSTS Antibody; CBP_HUMAN Antibody; Cyclic AMP responsive enhancer binding protein Antibody; Crebbp Antibody; CREB-binding protein Antibody; Rubinstein Taybi syndrome Antibody; KAT3A Antibody; EC:2.3.1.48 Antibody; CREBBP Antibody; CBP Antibody; RTS Antibody; CREB binding protein Antibody
Clonality
Polyclonal
Host
Rabbit
Species Reactivity
Human
Purity/Purification
Peptide Affinity Purified
Concentration
1 mg/ml (lot specific)
Specificity
Detects 265 kDa.
Preparation and Storage
Store at -20 degree C.
Matching Pairs
Unconjugated Antibody: CBP (MBS8000967)
PerCP Conjugated Antibody: CBP (MBS8000982)
PerCP Conjugated Antibody: CBP (MBS8000982)
Matching Pairs
Unconjugated Antibody: N/A (MBS8000982)
PerCP Conjugated Antibody: CBP (MBS8000982)
PerCP Conjugated Antibody: CBP (MBS8000982)
Molecular Weight
260,993 Da
OMIM
180849
Target
CBP
Immunogen
Synthetic peptide from the mid-protein of Human CBP (aa. 2100-2200)
Immunogen Species
Human
Cellular Localization
Cytoplasm; Nucleus
Conjugate
PerCP
Storage Buffer
PBS pH 7.4, 50% glycerol, 0.09% Sodium Azide
Product Categories/Family for anti-CBP antibody
Antibodies; Cell Signaling; Epigenetics and Nuclear Signaling; Chromatin Modifying Enzymes; Transcription; Stem Cells; Signaling Pathways; Wnt/Beta Catenin Pathway; Cancer; Cancer Metabolism; Cancer Lipid and Lipoprotein Metabolism; Cancer; Cancer Metab
Applications Tested/Suitable for anti-CBP antibody
Western Blot (WB)
Application Notes for anti-CBP antibody
WB: 1:1000
Western Blot (WB) of anti-CBP antibody
Western blot analysis of Human Cervical cancer cell line (HeLa) lysate showing detection of ~265.3 kDa CBP protein using Rabbit Anti-CBP Polyclonal Antibody (SPC-752). Lane 1: Molecular Weight Ladder (MW). Lane 2: HeLa. Load: 10 ug. Block: 5% Skim Milk in 1X TBST. Primary Antibody: Rabbit Anti-CBP Polyclonal Antibody (SPC-752) at 1:1000 for 2 hours at RT. Secondary Antibody: Goat Anti-Rabbit IgG: HRP at 1:4000 for 1 hour at RT. Color Development: ECL solution for 5 min at RT. Predicted/Observed Size: ~265.3 kDa.
Other Notes
Small volumes of anti-CBP antibody vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.
Additional Details
NCBI/Uniprot data below describe general gene information for CBP. It may not necessarily be applicable to this product.
NCBI Official Full Name
CREB-binding protein isoform b
NCBI Official Synonym Full Names
CREB binding protein
NCBI Official Symbol
CREBBP
NCBI Official Synonym Symbols
CBP; RSTS; KAT3A; RSTS1
UniProt Protein Name
CREB-binding protein
Protein Family
Citrate-binding protein
UniProt Gene Name
CREBBP
UniProt Synonym Gene Names
CBP
NCBI Protein Information
CREB-binding protein
NCBI Summary for CBP
This gene is ubiquitously expressed and is involved in the transcriptional coactivation of many different transcription factors. First isolated as a nuclear protein that binds to cAMP-response element binding protein (CREB), this gene is now known to play critical roles in embryonic development, growth control, and homeostasis by coupling chromatin remodeling to transcription factor recognition. The protein encoded by this gene has intrinsic histone acetyltransferase activity and also acts as a scaffold to stabilize additional protein interactions with the transcription complex. This protein acetylates both histone and non-histone proteins. This protein shares regions of very high sequence similarity with protein p300 in its bromodomain, cysteine-histidine-rich regions, and histone acetyltransferase domain. Mutations in this gene cause Rubinstein-Taybi syndrome (RTS). Chromosomal translocations involving this gene have been associated with acute myeloid leukemia. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Feb 2009]
Show more UniProt Comments for CBP
Acetylates histones, giving a specific tag for transcriptional activation. Also acetylates non-histone proteins, like NCOA3 and FOXO1. Binds specifically to phosphorylated CREB and enhances its transcriptional activity toward cAMP-responsive genes. Acts as a coactivator of ALX1. Acts as a circadian transcriptional coactivator which enhances the activity of the circadian transcriptional activators: NPAS2-ARNTL/BMAL1 and CLOCK-ARNTL/BMAL1 heterodimers. Acetylates PCNA; acetylation promotes removal of chromatin-bound PCNA and its degradation during nucleotide excision repair (NER) (PubMed:24939902).
Show more Precautions
All of MyBioSource's Products are for scientific laboratory research purposes and are not for diagnostic, therapeutics, prophylactic or in vivo use. Through your purchase, you expressly represent and warrant to MyBioSource that you will properly test and use any Products purchased from MyBioSource in accordance with industry standards. MyBioSource and its authorized distributors reserve the right to refuse to process any order where we reasonably believe that the intended use will fall outside of our acceptable guidelines.
Disclaimer
While every efforts were made to ensure the accuracy of the information provided in this datasheet, MyBioSource will not be liable for any omissions or errors contained herein. MyBioSource reserves the right to make changes to this datasheet at any time without prior notice.
It is the responsibility of the customer to report product performance issues to MyBioSource within 30 days of receipt of the product. Please visit our Terms & Conditions page for more information.
It is the responsibility of the customer to report product performance issues to MyBioSource within 30 days of receipt of the product. Please visit our Terms & Conditions page for more information.
Product Note
Select online data sheet information is drawn from bioinformatics databases, occasionally resulting in ambiguous or non-relevant product information. It is the responsibility of the customer to review, verify, and evaluate the information to make sure it matches their requirements before purchasing the kit. Our ELISA Kit assays are dynamic research tools and sometimes they may be updated and improved. If the format of this assay is important to you then please request the current manual or contact our technical support team with a presales inquiry before placing an order. We will confirm the current details of the assay. We cannot guarantee the sample manual posted online is the most current manual, it is intended to serve as an example only. Please refer to the instructions For Use provided with the assay kit for precise details.
Product PubMed Publications
Products associated with anti-CBP antibody
| Reference Product | PubMed Publications |
|---|---|
| NCOA1 antibody | >51 publications with CBP and NCOA1 |
| RELA antibody | >37 publications with CBP and RELA |
| TP53 antibody | >35 publications with CBP and TP53 |
| CREB1 antibody | >27 publications with CBP and CREB1 |
| NCOA3 antibody | >25 publications with CBP and NCOA3 |
| HIF1A antibody | >19 publications with CBP and HIF1A |
| IRF3 antibody | >18 publications with CBP and IRF3 |
| CTNNB1 antibody | >15 publications with CBP and CTNNB1 |
| CITED2 antibody | >7 publications with CBP and CITED2 |
| KAT2B antibody | >6 publications with CBP and KAT2B |
Pathways associated with anti-CBP antibody
| Products by Pathway | Pathway Diagram |
|---|---|
| Activation Of HOX Genes During Differentiation Pathway antibodies | Activation Of HOX Genes During Differentiation Pathway Diagram |
| Activation Of Anterior HOX Genes In Hindbrain Development During Early Embryogenesis Pathway antibodies | Activation Of Anterior HOX Genes In Hindbrain Development During Early Embryogenesis Pathway Diagram |
| Activation Of Gene Expression By SREBF (SREBP) Pathway antibodies | Activation Of Gene Expression By SREBF (SREBP) Pathway Diagram |
| Activation Of The TFAP2 (AP-2) Family Of Transcription Factors Pathway antibodies | Activation Of The TFAP2 (AP-2) Family Of Transcription Factors Pathway Diagram |
| Adherens Junction Pathway antibodies | Adherens Junction Pathway Diagram |
| Adherens Junction Pathway antibodies | Adherens Junction Pathway Diagram |
| Androgen Receptor Signaling Pathway antibodies | Androgen Receptor Signaling Pathway Diagram |
| Angiogenesis Pathway antibodies | Angiogenesis Pathway Diagram |
| Attenuation Phase Pathway antibodies | Attenuation Phase Pathway Diagram |
| BMAL1:CLOCK,NPAS2 Activates Circadian Gene Expression Pathway antibodies | BMAL1:CLOCK,NPAS2 Activates Circadian Gene Expression Pathway Diagram |
Diseases associated with anti-CBP antibody
| Disease Name | Pubmed Publications |
|---|---|
| Rubinstein-Taybi Syndrome Antibodies | >133 publications with CBP and Rubinstein-Taybi Syndrome |
| Inflammation Antibodies | >56 publications with CBP and Inflammation |
| Cardiovascular Diseases Antibodies | >45 publications with CBP and Cardiovascular Diseases |
| Necrosis Antibodies | >44 publications with CBP and Necrosis |
| Cell Transformation, Neoplastic Antibodies | >39 publications with CBP and Cell Transformation, Neoplastic |
| Breast Neoplasms Antibodies | >35 publications with CBP and Breast Neoplasms |
| Memory Disorders Antibodies | >33 publications with CBP and Memory Disorders |
| Cognition Disorders Antibodies | >32 publications with CBP and Cognition Disorders |
| Learning Disorders Antibodies | >30 publications with CBP and Learning Disorders |
| Lymphoma, Follicular Antibodies | >27 publications with CBP and Lymphoma, Follicular |
Organs/Tissues associated with anti-CBP antibody
| Organ/Tissue Name | Pubmed Publications |
|---|---|
| Brain Antibodies | >273 publications with CBP and Brain |
| Blood Antibodies | >161 publications with CBP and Blood |
| Nerve Antibodies | >77 publications with CBP and Nerve |
| Muscle Antibodies | >62 publications with CBP and Muscle |
| Liver Antibodies | >53 publications with CBP and Liver |
| Bone Antibodies | >52 publications with CBP and Bone |
| Heart Antibodies | >44 publications with CBP and Heart |
| Lung Antibodies | >40 publications with CBP and Lung |
| Thyroid Antibodies | >38 publications with CBP and Thyroid |
| Kidney Antibodies | >36 publications with CBP and Kidney |

